Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
作者信息
Badagliacca Roberto, Sciomer Susanna, Petrosillo Nicola
机构信息
Department of Cardiovascular and Respiratory Science, Sapienza University of Rome, Rome, Italy.
Department of Cardiovascular and Respiratory Science, Sapienza University of Rome, Rome, Italy.
出版信息
J Heart Lung Transplant. 2020 Jul;39(7):729-730. doi: 10.1016/j.healun.2020.04.007. Epub 2020 Apr 17.
Abstract
摘要
相似文献
1
Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?用于肺动脉高压和新冠肺炎的内皮素受体拮抗剂：是友还是敌？
J Heart Lung Transplant. 2020 Jul;39(7):729-730. doi: 10.1016/j.healun.2020.04.007. Epub 2020 Apr 17.
2
COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension.一名重型β地中海贫血合并重度肺动脉高压患者的新型冠状病毒肺炎
Hemoglobin. 2020 May;44(3):218-220. doi: 10.1080/03630269.2020.1779082. Epub 2020 Jun 18.
3
Clinical course of COVID-19 in pulmonary arterial hypertension patients.肺动脉高压患者感染新型冠状病毒肺炎的临床病程
Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):775-778. doi: 10.1016/j.rec.2020.05.015. Epub 2020 May 30.
4
Acute pulmonary embolism: An unseen villain in COVID-19.急性肺栓塞：COVID-19中一个隐匿的“恶棍”
Indian Heart J. 2020 May-Jun;72(3):218-219. doi: 10.1016/j.ihj.2020.05.003. Epub 2020 May 16.
5
Psoriasis-COVID 19 Infection: Treatment Options.银屑病-新冠病毒感染：治疗选择
Skinmed. 2020 Mar 1;18(2):81-82. eCollection 2020.
6
Management of venous thromboembolism during the COVID-19 pandemic.2019冠状病毒病大流行期间静脉血栓栓塞的管理
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):897-898. doi: 10.1016/j.jvsv.2020.05.005. Epub 2020 May 23.
7
"Long covid": the Dutch response.“长期新冠”：荷兰的应对措施。
BMJ. 2020 Aug 14;370:m3202. doi: 10.1136/bmj.m3202.
8
COVID-19 complications in children.儿童新冠病毒感染并发症
Br J Nurs. 2020 Nov 12;29(20):1146. doi: 10.12968/bjon.2020.29.20.1146.
9
DMCN 2020 highlights: COVID-19 and beyond.2020年数字医学与计算机神经科学会议亮点：新冠疫情及未来。
Dev Med Child Neurol. 2020 Dec;62(12):1345. doi: 10.1111/dmcn.14674.
10
From doctors as patients: a manifesto for tackling persisting symptoms of covid-19.从医生作为患者的角度：应对新冠长期症状的宣言。
BMJ. 2020 Sep 15;370:m3565. doi: 10.1136/bmj.m3565.
引用本文的文献
1
Transpulmonary Plasma Endothelin-1 Arterial:Venous Ratio Differentiates Survivors from Non-Survivors in Critically Ill Patients with COVID-19-Induced Acute Respiratory Distress Syndrome.经肺血浆内皮素-1 动静脉比值区分 COVID-19 诱导的急性呼吸窘迫综合征危重症患者的幸存者与非幸存者。
Int J Mol Sci. 2024 Oct 2;25(19):10640. doi: 10.3390/ijms251910640.
2
Proposed Mechanisms for the Relationship between Periodontal Diseases and the Severity of Covid-19: Common Pathogens, Inflammatory Mediators, and Risk Factors.牙周疾病与新冠病毒肺炎严重程度之间关系的潜在机制：共同病原体、炎症介质及危险因素
Adv Biomed Res. 2024 Apr 27;13:28. doi: 10.4103/abr.abr_116_23. eCollection 2024.
3
Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors.新冠病毒感染所致儿童肺动脉高压及磷酸二酯酶-5抑制剂的应用
F1000Res. 2022 Sep 12;10:792. doi: 10.12688/f1000research.53966.2. eCollection 2021.
4
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?意大利在 COVID-19 时代的肺动脉高压悖论：疾病进展的风险就在眼前吗？
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02276-2021. Print 2022 Oct.
5
Pulmonary artery targeted therapy in treatment of COVID-19 related ARDS. Literature review.肺靶向治疗在治疗 COVID-19 相关 ARDS 中的应用。文献回顾。
Biomed Pharmacother. 2022 Feb;146:112592. doi: 10.1016/j.biopha.2021.112592. Epub 2021 Dec 25.
6
Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19.是否与内皮功能障碍和血栓形成有关？COVID-19 的秘密。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211042940. doi: 10.1177/10760296211042940.
7
Cardiovascular Disease Complicating COVID-19 in the Elderly.老年 COVID-19 合并心血管疾病。
Medicina (Kaunas). 2021 Aug 17;57(8):833. doi: 10.3390/medicina57080833.
8
Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine.预测、预防和个性化（3P）医学框架下的内皮素-1轴
EPMA J. 2021 Aug 4;12(3):265-305. doi: 10.1007/s13167-021-00248-z. eCollection 2021 Sep.
9
Lung histopathological findings in COVID-19 disease - a systematic review.新型冠状病毒肺炎的肺部组织病理学发现——一项系统综述
Infect Agent Cancer. 2021 May 17;16(1):34. doi: 10.1186/s13027-021-00369-0.
10
Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform.利用人工智能集成生物模拟平台加速治疗 COVID-19 的肺动脉高压药物的重新定位和开发。
Molecules. 2021 Mar 29;26(7):1912. doi: 10.3390/molecules26071912.
本文引用的文献
1
SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death.严重急性呼吸综合征冠状病毒开放阅读框 3a 驱动多模式坏死性细胞死亡。
Cell Death Dis. 2018 Sep 5;9(9):904. doi: 10.1038/s41419-018-0917-y.
2
Lipopolysaccharide-induced necroptosis of brain microvascular endothelial cells can be prevented by inhibition of endothelin receptors.通过抑制内皮素受体可预防脂多糖诱导的脑微血管内皮细胞坏死性凋亡。
Physiol Res. 2018 Jun 27;67(Suppl 1):S227-S236. doi: 10.33549/physiolres.933842.
3
RIP3: a molecular switch for necrosis and inflammation.RIP3：坏死和炎症的分子开关。
Genes Dev. 2013 Aug 1;27(15):1640-9. doi: 10.1101/gad.223321.113.
4
Many stimuli pull the necrotic trigger, an overview.许多刺激因素引发了细胞坏死，概述如下。
Cell Death Differ. 2012 Jan;19(1):75-86. doi: 10.1038/cdd.2011.164. Epub 2011 Nov 11.
5
Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore.严重急性呼吸综合征（SARS）的肺部病理学：对新加坡8例尸检病例的研究
Hum Pathol. 2003 Aug;34(8):743-8. doi: 10.1016/s0046-8177(03)00367-8.
Zotero 插件